Views & Analysis Are microtaggants the key to making medicines smarter? Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients.
News Third death reported with a Sarepta gene therapy A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
